 SAN CLEMENTE, CA and SAN DIEGO, CA ACCESSWIRE June 15, 2021 ReShape Lifesciences Inc. OTCQB:RSLS and Obalon Therapeutics, Inc. NASDAQ:OBLN announced today the anticipated closing of their previously announced merger to be effective after the close of the market today, June 15, 2021. The shares of common stock of the combined company are expected to commence trading on The Nasdaq Capital Market on Wednesday, June 16, 2021, under the name ReShape Lifesciences Inc. and the trading symbol RSLS. 